Dr. Roger Hershline, Founder of CureHIV, Inc. and Global Humanceuticals, Inc., Hosting Fifth Session of the International HIV/AIDS Programs at the World AIDS Day in China, 2006

Dr. Roger Hershline, Founder of CureHIV, Inc. and Global Humanceuticals, Inc., Hosting Fifth Session of the International HIV/AIDS Programs at the World AIDS Day in China, 2006

November 29, 2006

    TIANJIN, China, Nov. 29 /Xinhua-PRNewswire/ -- The
Chinese government has kindly invited Dr. Roger Hershline
to host the Fifth Session of the International HIV/AIDS
Programs Cooperation and New Technology/Product Showcase at
the World AIDS Day in China, 2006.  Dr. Roger Hershline will
present insight into the CureHIV, Inc. public charity that
he has established and describe the benefits of his new
microbicide for HIV with reference to Global
Humanceuticals, Inc. and China.  As host of the conference
he will also have the distinct honor of introducing many
speakers including the world-renowned discoverer of the HIV
virus, Dr. Luc Montagnier.

    (Photo: 
http://www.newscom.com/cgi-bin/prnh/20061129/CLW002 )

    The conferees from more than 30 different countries are
mainly professionals and executives working in the fields of
HIV/AIDS diagnosis, therapy, drug design, pharmaceutical
industry, policy and regulation, and venture capital
companies.  All of them are participating in order to look
for potential opportunities for future partnerships in
research, development, technology and transfer.

    Being aware that Dr. Hershline's laboratory has
discovered compounds as potential antiviral agents
specifically for HIV/AIDS treatment, the Chinese believe
that Dr. Roger Hershline's speech at the conference will be
of highest interest to all other parties participating in
the event and especially so to Chinese officers and
researchers.

    China plans to make great efforts to restrict the rapid
epidemic spread of HIV/AIDS across their country, to no more
than 1.5 million HIV/AIDS cases by the end of 2010. 
Currently, China has listed HIV/AIDS prevention and control
research as key State scientific research projects to
explore efficient treatment for AIDS.

    The Chinese Government believes Dr. Hershline's
fruitful research will be attractive and impressive to his
worldwide colleagues.  They have planned meetings for him
with governmental and organizational officers who will
introduce their domestic policies for importing
antiretroviral agents and other opportunities for building
cooperation partnerships.

    For further information see http://www.curehiv.us 

    For more information, please contact:

     Dr. Roger Hershline
     Email:  [e-mail] 

SOURCE  Roger Hershline